Michael J. Ashton

531 total citations
19 papers, 409 citations indexed

About

Michael J. Ashton is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Michael J. Ashton has authored 19 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Surgery. Recurrent topics in Michael J. Ashton's work include Cholesterol and Lipid Metabolism (4 papers), Synthesis and Catalytic Reactions (3 papers) and Asthma and respiratory diseases (3 papers). Michael J. Ashton is often cited by papers focused on Cholesterol and Lipid Metabolism (4 papers), Synthesis and Catalytic Reactions (3 papers) and Asthma and respiratory diseases (3 papers). Michael J. Ashton collaborates with scholars based in United Kingdom, Australia and United States. Michael J. Ashton's co-authors include David Raeburn, Malcolm N. Palfreyman, Michael Jaye, Jan‐Anders Karlsson, Stephen E. Webber, Jessica Karlsson, Nigel Vicker, David Cook, Garry Fenton and Andrew J. Ratcliffe and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Drug Discovery Today.

In The Last Decade

Michael J. Ashton

18 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Ashton United Kingdom 11 236 135 81 57 44 19 409
John S. Major United Kingdom 13 282 1.2× 163 1.2× 46 0.6× 26 0.5× 33 0.8× 27 578
Norman L. Colbry United States 12 174 0.7× 199 1.5× 56 0.7× 30 0.5× 46 1.0× 19 401
Roger P. Dickinson United Kingdom 15 215 0.9× 266 2.0× 121 1.5× 46 0.8× 16 0.4× 26 636
J. Y. GAUTHIER Canada 11 240 1.0× 218 1.6× 118 1.5× 62 1.1× 51 1.2× 20 582
Lin Chu United States 8 148 0.6× 111 0.8× 78 1.0× 61 1.1× 30 0.7× 13 364
R. A. Krause United States 11 194 0.8× 102 0.8× 79 1.0× 12 0.2× 74 1.7× 17 413
Julie M. Miyashiro United States 12 164 0.7× 355 2.6× 119 1.5× 42 0.7× 39 0.9× 15 536
E. Granzer Germany 12 200 0.8× 189 1.4× 121 1.5× 34 0.6× 11 0.3× 29 478
J.B.H. Warneck United Kingdom 13 170 0.7× 232 1.7× 52 0.6× 28 0.5× 28 0.6× 17 391
Charles Q. Meng Canada 10 141 0.6× 255 1.9× 67 0.8× 15 0.3× 49 1.1× 16 482

Countries citing papers authored by Michael J. Ashton

Since Specialization
Citations

This map shows the geographic impact of Michael J. Ashton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Ashton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Ashton more than expected).

Fields of papers citing papers by Michael J. Ashton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Ashton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Ashton. The network helps show where Michael J. Ashton may publish in the future.

Co-authorship network of co-authors of Michael J. Ashton

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Ashton. A scholar is included among the top collaborators of Michael J. Ashton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Ashton. Michael J. Ashton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ashton, Michael J., et al.. (2018). Some issues affecting potential stakeholder uptake of sustainable aviation fuel within Australia: a case study conducted at Darwin International Airport. Australian Journal of Mechanical Engineering. 18(sup1). S95–S107. 7 indexed citations
2.
Ashton, Michael J., Christopher Lawrence, Jessica Karlsson, et al.. (1997). ChemInform Abstract: Antiinflammatory 17β‐Thioalkyl‐16α,17α‐ketal and ‐ acetal Androstanes: A New Class of Airway Selective Steroids for the Treatment of Asthma.. ChemInform. 28(14). 1 indexed citations
3.
Astles, Peter C., Michael J. Ashton, Andrew W. Bridge, et al.. (1996). Acyl-CoA:CholesterolO-Acyltransferase (ACAT) Inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as Potent Inhibitors of ACAT. Journal of Medicinal Chemistry. 39(7). 1423–1432. 14 indexed citations
4.
Ashton, Michael J., Michael Jaye, & Justin C. Mason. (1996). New perspectives in lead generation I: Discovery of biological targets. Drug Discovery Today. 1(1). 11–15. 4 indexed citations
5.
Ashton, Michael J., Christopher Lawrence, Jan‐Anders Karlsson, et al.. (1996). Anti-inflammatory 17β-Thioalkyl-16α,17α-ketal and -acetal Androstanes:  A New Class of Airway Selective Steroids for the Treatment of Asthma. Journal of Medicinal Chemistry. 39(25). 4888–4896. 35 indexed citations
6.
Ashton, Michael J., Thomas J. Brown, Garry Fenton, et al.. (1996). New Low-Density Lipoprotein Receptor Upregulators Acting via a Novel Mechanism. Journal of Medicinal Chemistry. 39(17). 3343–3356. 8 indexed citations
7.
Smith, Christopher, Michael J. Ashton, Raymond C. Bush, et al.. (1996). RP 73163: A bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor. Bioorganic & Medicinal Chemistry Letters. 6(1). 47–50. 11 indexed citations
8.
Ashton, Michael J., et al.. (1996). New perspectives in lead generation II: Evaluating molecular diversity. Drug Discovery Today. 1(2). 71–78. 38 indexed citations
9.
Webber, Stephen E., Martyn Foster, David Raeburn, et al.. (1995). Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP‐specific phosphodiesterase: comparison with rolipram. British Journal of Pharmacology. 115(1). 39–46. 69 indexed citations
10.
Ashton, Michael J., David Cook, Garry Fenton, et al.. (1994). Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and Analogs. Journal of Medicinal Chemistry. 37(11). 1696–1703. 93 indexed citations
11.
12.
Harris, Neil V., et al.. (1992). Acyl-CoA: cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT. Journal of Medicinal Chemistry. 35(23). 4384–4392. 29 indexed citations
13.
Ashton, Michael J., et al.. (1992). RP 70676: A potent systematically available inhibitor of acyl-CoA:cholesterol O-acyl transferase (ACAT). Bioorganic & Medicinal Chemistry Letters. 2(5). 375–380. 22 indexed citations
14.
Taylor, John B., et al.. (1989). Synthesis of 6-Aryl-4-hydroxypiperidin-2-ones and a Possible Applications to the Synthesis of a Novel HMG-CoA Reductase Inhibitor. Heterocycles. 28(2). 1015–1015. 18 indexed citations
15.
Ashton, Michael J., et al.. (1984). Heterocyclic analogs of chlorcyclizine with potent hypolipidemic activity. Journal of Medicinal Chemistry. 27(10). 1245–1253. 13 indexed citations
16.
Ashton, Michael J., Robert F. Chapman, & A. Loveless. (1980). Acylthioxanthenes: agents which selectively reduce decerebrate rigidity in the cat. Journal of Medicinal Chemistry. 23(6). 653–657. 3 indexed citations
17.
Ashton, Michael J., A. S. Bailey, & Ewart R. H. Jones. (1974). Microbiological hydroxylation. Part XII. Comparative behaviour of D-homogonane (perhydrochrysene) ketones and steroids. Journal of the Chemical Society Perkin Transactions 1. 0(14). 1658–1658.
18.
Ashton, Michael J., A. S. Bailey, & Ewart R. H. Jones. (1974). Microbiological hydroxylation. Part XIII. Cyclododecanone and cyclopentadecanone as substrates for steroid-hydroxylating fungi. Journal of the Chemical Society Perkin Transactions 1. 0(14). 1665–1665. 1 indexed citations
19.
Ashton, Michael J., et al.. (1973). The absorption, metabolism and excretion of disodium cromoglycate in nine animal species. Toxicology and Applied Pharmacology. 26(3). 319–328. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John S. Major Breakdown of academic impact, for papers by Norman L. Colbry Breakdown of academic impact, for papers by Roger P. Dickinson Breakdown of academic impact, for papers by J. Y. GAUTHIER Breakdown of academic impact, for papers by Lin Chu Breakdown of academic impact, for papers by R. A. Krause Breakdown of academic impact, for papers by Julie M. Miyashiro Breakdown of academic impact, for papers by E. Granzer Breakdown of academic impact, for papers by J.B.H. Warneck Breakdown of academic impact, for papers by Charles Q. Meng
Rankless by CCL
2026